22 May 2013
Keywords: genzyme, seeking, euro, approval, ceredase, presently, approved
Article | 13 April 1992
Presently approved in the USA as an enzyme replacement therapy for patients with Gaucher disease type I, Genzyme Corp's Ceredase ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.